A -year-old man with a known history of decompensated cirrhosis secondary to alcohol use disorder presents to the emergency department reporting a two-day history of fever, fatigue, and worsening abdominal swelling. His temperature is (), blood pressure is , and pulse is . Physical examination demonstrates a markedly distended abdomen with positive shifting dullness and mild, diffuse tenderness to palpation. There is no rebound tenderness or abdominal rigidity. A diagnostic paracentesis is promptly performed. The ascitic fluid analysis reveals a total leukocyte count of with segmented neutrophils. Based on these findings, which of the following is the most appropriate targeted pharmacotherapy for this patient's current condition?
- Intravenous ceftriaxoneCevap
- BIntravenous vancomycin and cefepime
- CIntravenous metronidazole
- DOral ciprofloxacin
- EOral rifaximin
Cevap
The most appropriate targeted pharmacotherapy is intravenous ceftriaxone.
The patient has spontaneous bacterial peritonitis (SBP), which is diagnosed when the absolute neutrophil count (ANC) in the ascitic fluid is . In this scenario, the calculated ANC is ( of ). SBP occurs in patients with cirrhosis primarily due to the translocation of enteric bacteria (most commonly Gram-negative bacilli like Escherichia coli and Klebsiella species) across the edematous bowel wall into the ascitic fluid. The standard, first-line empiric treatment for community-acquired SBP is an intravenous third-generation cephalosporin, such as ceftriaxone or cefotaxime. These agents provide excellent targeted coverage for the expected pathogens while adhering to antibiotic stewardship principles by avoiding unnecessarily broad coverage.
Adım Adım Çözüm
Anahtar Kavram
Spontaneous bacterial peritonitis is diagnosed with an ascitic fluid absolute neutrophil count and is optimally treated with a third-generation cephalosporin to provide targeted empiric coverage against translocated enteric Gram-negative bacteria.